S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
S&P 500   3,307.27 (-0.44%)
DOW   29,021.63 (-0.56%)
QQQ   223.53 (-0.15%)
AAPL   317.33 (-0.12%)
FB   220.32 (-0.45%)
MSFT   165.95 (+0.15%)
GOOGL   1,481.77 (-0.16%)
AMZN   1,879.20 (-0.44%)
NVDA   250.05 (+0.00%)
BABA   218.25 (-1.85%)
MU   59.47 (+0.51%)
GE   11.73 (+3.17%)
TSLA   574.76 (+0.91%)
AMD   51.08 (-0.68%)
T   38.66 (-0.97%)
ACB   2.09 (+2.45%)
F   9.03 (-1.42%)
NFLX   336.07 (+3.09%)
DIS   141.73 (-1.58%)
GILD   63.21 (-0.35%)
Log in
(Ad)
A Jump Trader caught a 58% gain in just ONE DAY... Another, $2,080 in profit in just ONE DAY... Every day you miss out on this could be costing you... $500... $1,000... Even $2,080 a day...

NYSE:PRX - Par Pharmaceutical Companies Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.11
0.00 (0.00 %)
(As of 05/24/2018)
Add
Today's Range
$0.11
Now: $0.11
$0.12
50-Day Range N/A
52-Week Range N/A
Volume2.85 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Par Pharmaceutical Companies, Inc is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc, is in the business of developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States. The Company operates primarily in the United States as two business segments: Par Pharmaceutical (Par), its generic products division, and Strativa Pharmaceuticals (Strativa), its branded products division. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
CUSIPN/A
Phone+1-845-5735500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PRX News and Ratings via Email

Sign-up to receive the latest news and ratings for PRX and its competitors with MarketBeat's FREE daily newsletter.


Par Pharmaceutical Companies (NYSE:PRX) Frequently Asked Questions

What is Par Pharmaceutical Companies' stock symbol?

Par Pharmaceutical Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRX."

Has Par Pharmaceutical Companies been receiving favorable news coverage?

Press coverage about PRX stock has been trending somewhat positive on Thursday, according to InfoTrie. The research group scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Par Pharmaceutical Companies earned a news impact score of 1.6 on InfoTrie's scale. They also assigned news headlines about the healthcare company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Par Pharmaceutical Companies.

What other stocks do shareholders of Par Pharmaceutical Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Par Pharmaceutical Companies investors own include Gol Linhas Aereas Inteligentes (GOL), Wildhorse Resource Development (WRD), Baidu (BIDU), Amicus Therapeutics (FOLD), U.S. Global Investors (GROW), Inovio Pharmaceuticals (INO), Monster Beverage (MNST), Rite Aid (RAD), Rock-Tenn (RKT) and Broadcom (AVGO).

Who are Par Pharmaceutical Companies' key executives?

Par Pharmaceutical Companies' management team includes the folowing people:
  • Paul V. Campanelli, Chief Executive Officer (Age 54)
  • Michael A. Tropiano, Chief Financial Officer, Executive Vice President (Age 57)
  • Terrance John Coughlin, Chief Operating Officer (Age 52)
  • Thomas J. Haughey, Chief Administrative Officer, General Counsel (Age 51)

What is Par Pharmaceutical Companies' stock price today?

One share of PRX stock can currently be purchased for approximately $0.11.

What is Par Pharmaceutical Companies' official website?

The official website for Par Pharmaceutical Companies is http://www.parpharm.com/.

How can I contact Par Pharmaceutical Companies?

Par Pharmaceutical Companies' mailing address is 1 Ram Ridge Rd, CHESTNUT RIDGE, NY 10977-6714, United States. The healthcare company can be reached via phone at +1-845-5735500.


MarketBeat Community Rating for Par Pharmaceutical Companies (NYSE PRX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  107 (Vote Outperform)
Underperform Votes:  96 (Vote Underperform)
Total Votes:  203
MarketBeat's community ratings are surveys of what our community members think about Par Pharmaceutical Companies and other stocks. Vote "Outperform" if you believe PRX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel